•
Apr 30, 2021

HealthEquity Q1 2022 Earnings Report

HealthEquity's first quarter results were reported, showing a slight decrease in revenue and a net loss compared to the previous year, but with growth in HSAs and total HSA assets.

Key Takeaways

HealthEquity reported a decrease in revenue and a net loss for the first quarter of fiscal year 2022. While revenue decreased by 3% to $184.2 million, the company saw a 9% increase in the number of HSAs to 5.8 million and a 31% increase in total HSA assets to $15.0 billion. The company also completed its acquisition of Luum and entered into agreements to acquire Further and transition the Fifth Third Bank HSA portfolio.

Revenue decreased by 3% to $184.2 million compared to the same quarter last year.

Net loss was $2.6 million, a shift from the $1.8 million net income in the first quarter of the previous fiscal year.

The company sold 5,750,000 shares of common stock, yielding net proceeds of $456.6 million.

Total HSAs increased by 9% to 5.8 million, and total HSA assets increased by 31% to $15.0 billion.

Total Revenue
$184M
Previous year: $190M
-3.1%
EPS
$0.38
Previous year: $0.43
-11.6%
Total HSAs
5.8M
Previous year: 5.4M
+7.4%
HSAs with investments
371K
Previous year: 245K
+51.4%
Total Accounts
12.8M
Previous year: 12.7M
+0.8%
Gross Profit
$103M
Previous year: $108M
-4.6%
Cash and Equivalents
$737M
Previous year: $171M
+330.6%
Free Cash Flow
$28.4M
Previous year: $7.52M
+278.3%
Total Assets
$3.16B
Previous year: $2.56B
+23.4%

HealthEquity

HealthEquity

HealthEquity Revenue by Segment

Forward Guidance

For the fiscal year ending January 31, 2022, HealthEquity expects revenues of $755 million to $765 million, a net loss between $19 million and $15 million, non-GAAP net income between $122 million and $126 million, and Adjusted EBITDA of $241 million to $247 million. This outlook does not include any potential impact from the acquisitions of Further or the Fifth Third Bank HSA portfolio.

Positive Outlook

  • Revenue outlook between $755 million and $765 million.
  • Non-GAAP net income outlook between $122 million and $126 million.
  • Adjusted EBITDA outlook between $241 million and $247 million.
  • Expects non-GAAP net income per diluted share of $1.45 to $1.50.
  • Based on an estimated 84 million diluted weighted-average shares outstanding.

Challenges Ahead

  • Net loss outlook between $19 million and $15 million.
  • Net loss of $0.23 to $0.18 per diluted share.
  • Outlook does not include any potential impact from the acquisitions of Further or the Fifth Third Bank HSA portfolio.
  • Achieved approximately $65 million of the approximately $80 million in annualized ongoing net synergies expected to achieve by the end of fiscal year 2022.
  • Past performance is not necessarily indicative of future results.

Revenue & Expenses

Visualization of income flow from segment revenue to net income